Thirty/70 adenocarcinomas (42.9%), 21/49 of which were ADBF, 2/8 ADC and 7/13 BAC, were positive for IL-12Rβ2 expression (Table 1 and Fig. 1A, d). This evidence concerns the gene IL12RB2 and minimally invasive lung adenocarcinoma.